Race to develop Ebola vaccine heats up amid deadly outbreak in DRC
Non-profit organizations are accelerating efforts to develop a vaccine for a rare Bundibugyo strain of Ebola currently causing a deadly outbreak in the DRC and Uganda. The WHO has identified a promising single-dose candidate, with clinical trials expected to begin in the coming months.
Why it matters
This outbreak involves a rare strain for which no licensed vaccines or treatments currently exist, posing a significant public health threat.
Efforts are ramping up to rapidly develop a vaccine for the rare strain of Ebola driving a deadly outbreak. ( Reuters: Gradel Muyisa Mumbere )
The article provides factual reporting on public health efforts without emotive language or political framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in